Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Stem Cells Hold Keys for Idiopathic Pulmonary Fibrosis

Posted by pamela@stemsave.com on Nov 4, 2016 5:46:05 PM

Researchers from the University of Pittsburg School of Medicine are utilizing mesenchymal stem cells [MSCs] to develop a treatment for Idiopathic Pulmonary Fibrosis (IPF). MSCs possess valuable properties that make them particularly suitable for potential treatments – chief amongst them are; their plasticity [ability to differentiate into a particular tissue type], their anti-inflammatory capabilities and, their immunomodulatory properties. Currently, there are five Phase 1 clinical trials registered utilizing MSCs to treat IPF.

Read More

Topics: idiopathic pulmonary fibrosis, regenerative therapies, dental pulp, mesenchymal stem cells, autologous stem cells

FDA Approves Clinical Trial Using Mesenchymal Stem Cells Idiopathic Pulmonary Fibrosis

Posted by pamela@stemsave.com on Nov 27, 2012 5:00:55 AM

 

 

 

 

 

 

 

 

Researchers at University of Miami Health System receive FDA approval for the first U.S. clinical trial using mesenchymal stem cells to treat idiopathic pulmonary fibrosis. Mesenchymal stem cells are multipotent adult stem cells that can be isolated from bone marrow, teeth, and fat. Mesenchymal stem cells have demonstrated the ability to differentiate into bone, cartilage, cardiomyocites, muscle, neuronal cells, insulin producing pancreatic beta cells and more.

Read More

Topics: stemsaveblog, clinical trials, idiopathic pulmonary fibrosis, Stemcells, Teeth, dentalstemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Recent Posts

Posts by Topic

see all